Uncategorised - European Medical Journal

Neuropsychiatric Problems in Primary Ciliary Dyskinesia? First, Go to Sleep

Sleep disorders are characterized by the impairment of the quality, timing, and amount of sleep, which results in…

ATS 2023 Interview: Debra M. Boyer

Debra M. Boyer | Division of Pulmonary Medicine, Department of Pediatrics, Nationwide Children’s Hospital, The Ohio State University…

Beginning with the Ace of Spades and Ending with the Clot of Hearts: Hypereosinophilic Syndrome with a Left Ventricular Thrombus

Idiopathic hypereosinophilic syndrome (IHS) is characterized by persistent eosinophilia greater than 1,500 /µL for more than 6 months with…

ATS 2023 Interview: Michelle Gong

An interview with Michelle Gong, Director, Department of Medicine Critical Care Research, Albert Einstein College of Medicine, New York, USA.

A Rare Case of Samter’s Triad due to Acetaminophen

Aspirin-exacerbated respiratory disease (AERD), also known as Samter’s triad, is characterized by the presence of bronchial asthma, nasal polyps, and hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs (NSAID).

An Unusual Case of Hymenoptera Venom-Induced Angioedema

Angioedema is a localized submucosal reaction that can be part of a systemic anaphylactic response. The etiology can be difficult to…

IME Rheumatology Webinar | Key Insights from EULAR 2023 - An Interdisciplinary Expert Roundtable Discussion

Join us for an interdisciplinary expert roundtable discussion to gain a deeper understanding of emerging data from EULAR 2023 and real-world evidence with biosimilars. Joined by Rheumatology experts Xenofon Baraliakos and Muhammad Nisar, and Gastroenterolog expert Fraser Cummings.

Oncology under the microscope

This infographic explores the intricacies of the oncology market, assessing its impact on patients, its global market share and the new drugs to watch in the oncology space.

Breast Ultrasound Recommendations May Not Be Targeting Right Patients

Supplementary whole-breast ultrasound recommendations may not be targeting the patients who are most likely to benefit from it…

Expanding the Role of 18F-fluorodeoxyglucose PET in Melanoma Treatment?

New data supports a bigger role for 18F-fluorodeoxyglucose (FDG) PET/CT in the treatment of melanoma. Read more…